[Histonet] Surgipath's O-fix for breast fixation.

Weems, Joyce JWEEMS <@t> sjha.org
Mon Apr 7 15:51:08 CDT 2008


And the most important aspect is that a patient can be denied a clinical trial if this protocol is not followed specifically, j 

-----Original Message-----
From: histonet-bounces <@t> lists.utsouthwestern.edu [mailto:histonet-bounces <@t> lists.utsouthwestern.edu] On Behalf Of Rene J Buesa
Sent: Monday, April 07, 2008 4:47 PM
To: JOHN P COLEMAN; histonet <@t> lists.utsouthwestern.edu
Subject: Re: [Histonet] Surgipath's O-fix for breast fixation.

When a protocol is approved, it is so to be used as approved and does not allow deviations, IF you want to avoid any payment problems.
  It has nothing to do with adequacy, but with fully following the protocol, regardless of any consideration.
  What is accepted is NBF, nothing else.
  René J. 

JOHN P COLEMAN <JPCOLEMA <@t> sentara.com> wrote:
  We routinely use Surgipath's O-fix on breast tissue for subsequent Her-2 testing via IHC and FISH. Is this now disallowed? According to the labeling, O-fix is a formalin based fixative with ethanol and acetic acid added. I would consider it an alcohol based fixative and disallowed only in the absence of the formalin. 


John P.J. Coleman HT(ASCP)QIHC
Clinical Specialist
Anatomic Pathology
Sentara Laboratory Services
Cell/Voicemail(757)335-2159
pager: (757)456-6695
_______________________________________________
Histonet mailing list
Histonet <@t> lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet


       
---------------------------------
You rock. That's why Blockbuster's offering you one month of Blockbuster Total Access, No Cost.
_______________________________________________
Histonet mailing list
Histonet <@t> lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet
Confidentiality Notice:
This email, including any attachments is the 
property of Catholic Health East and is intended 
for the sole use of the intended recipient(s).  
It may contain information that is privileged and 
confidential.  Any unauthorized review, use,
disclosure, or distribution is prohibited. If you are 
not the intended recipient, please reply to the 
sender that you have received the message in 
error, then delete this message.





More information about the Histonet mailing list